Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1681 AL 1695

Repurposing Niclosamide as a plausible neurotherapeutic in autism spectrum disorders, targeting mitochondrial dysfunction: a strong hypothesis

Varma M, Bhandari R, Kuhad A.

Metab Brain Dis. 2024 Mar;39(3):387-401. doi: 10.1007/s11011-023-01247-x. Epub 2023 Jun 7.

An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders

Borrego-Ruiz A, Borrego JJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110861. doi: 10.1016/j.pnpbp.2023.110861. Epub 2023 Sep 9.

Regulatory mechanism of circular RNAs in neurodegenerative diseases

Xiao F, He Z, Wang S, Li J, Fan X, Yan T, Yang M, Yang D.

CNS Neurosci Ther. 2024 Apr;30(4):e14499. doi: 10.1111/cns.14499. Epub 2023 Oct 21.

Targeting GM2 Ganglioside Accumulation in Dementia: Current Therapeutic Approaches and Future Directions

Kumar S, Panda SP.

Curr Mol Med. 2024;24(11):1329-1345. doi: 10.2174/0115665240264547231017110613.

Ferroptosis Induced by Pollutants: An Emerging Mechanism in Environmental Toxicology

Yang L, Cai X, Li R.

Environ Sci Technol. 2024 Feb 6;58(5):2166-2184. doi: 10.1021/acs.est.3c06127. Epub 2024 Jan 26.

Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo

Krut' VG, Kalinichenko AL, Maltsev DI, Jappy D, Shevchenko EK, Podgorny OV, Belousov VV.

Prog Neurobiol. 2024 Apr;235:102600. doi: 10.1016/j.pneurobio.2024.102600. Epub 2024 Mar 26.

Chaperone-Mediated Autophagy in Brain Injury: A Double-Edged Sword with Therapeutic Potentials

Zhang H, Tian Y, Ma S, Ji Y, Wang Z, Xiao P, Xu Y.

Mol Neurobiol. 2024 Dec;61(12):10671-10683. doi: 10.1007/s12035-024-04230-4. Epub 2024 May 22.

Globus pallidus is not independent from striatal direct pathway neurons: an up-to-date review

Fujiyama F, Karube F, Hirai Y.

Mol Brain. 2024 Jun 7;17(1):34. doi: 10.1186/s13041-024-01107-4.

Bee venom as a promising therapeutic strategy in central nervous system diseases

Vahidinia Z, Barati S, Azami Tameh A, Bagheri-Mohammadi S, Garshasebi A.

Neuropeptides. 2024 Oct;107:102451. doi: 10.1016/j.npep.2024.102451. Epub 2024 Jun 22.

Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)

Mahboubi-Rabbani M, Abdolghaffari AH, Ghesmati M, Amini A, Zarghi A.

Expert Opin Ther Pat. 2024 Sep;34(9):733-757. doi: 10.1080/13543776.2024.2373771. Epub 2024 Jul 3.

Aging and "Age-Related" Diseases - What Is the Relation?

Kopp W.

Aging Dis. 2024 Jun 28;16(3):1316-1346. doi: 10.14336/AD.2024.0570.

Research Progress of Fluorescent Probes for Detection of Glutathione (GSH): Fluorophore, Photophysical Properties, Biological Applications

Wang Y, Li Y, Cao J, Yang X, Huang J, Huang M, Gu S.

Molecules. 2024 Sep 12;29(18):4333. doi: 10.3390/molecules29184333.

Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives

Nurkolis F, Utami TW, Alatas AI, Wicaksono D, Kurniawan R, Ratmandhika SR, Sukarno KT, Pahu YGP, Kim B, Tallei TE, Tjandrawinata RR, Alhasyimi AA, Surya R, Helen H, Halim P, Muhar AM, Syahputra RA.

Front Aging. 2024 Oct 17;5:1462569. doi: 10.3389/fragi.2024.1462569. eCollection 2024.

Targeting Neurological Disorders with Stilbenes: Bridging the Preclinical-Clinical Gap

Begh MZA, Khan J, Zehravi M, Sweilam SH, Raja AD, Muthukumar A, Haque MA, Kar NR, Singh LP, Priya BD, Alshehri MA, Ahmad I, Kang S, Moon S, Park MN, Emran TB, Kim B.

Int J Biol Sci. 2024 Oct 7;20(14):5474-5494. doi: 10.7150/ijbs.102032. eCollection 2024.

Gut microbiota in health and disease: advances and future prospects

Zhang Y, Wang H, Sang Y, Liu M, Wang Q, Yang H, Li X.

MedComm (2020). 2024 Nov 20;5(12):e70012. doi: 10.1002/mco2.70012. eCollection 2024 Dec.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias